Best in Biotech 18 Jul 2017
Is DNA the Future? The Best Biotech Talks of the Year
…In his keynote at SynBioBeta in London this year, he gave an overview of how the field has evolved since its beginnings in the early 2000s, and how to tackle…
Search Results for: London
Interview 31 May 2021
What’s Ahead for European Biotech Startups After Covid?
…sciences startup scene in Europe. We know the golden triangle – Oxford, Cambridge, and London – creates more biotech startups than most places in the world. So do I think…
News and Trends 23 Jan 2017
New Fundraising Boosts Ultra-Rapid STD Detection
…part of the ‘Precise‘ project at St George’s University of London that are aimed at integrating information about antibiotic resistance in STD tests. Rapid diagnostics can be key for the…
News and Trends 6 Jun 2018
German DNA Treatment Reduces Ulcerative Colitis Symptoms
…Phase II trial for its oral immune modulator to treat ulcerative colitis. London biotech TopiVert obtained positive Phase I results to treat the same indication, which may eventually provide an…
ADVERTISEMENT
News and Trends 8 Dec 2016
The Munich Biotech Mafia expand to the US with a New TCR Startup
…off with a €41.2M ($44.5M) Series A round led by MPM Capital in the US and F2 Ventures in London. The new company, based in Boston, was founded last year…
More News! 12 Apr 2018
Graphene Skin Patch Measures Blood Sugar Without a Needle
…are already in development. For example, GlucoSense, based in London, is developing a device that can obtain measurements in less than 30 seconds. Integrity Applications, an Israeli company, has developed…
News and Trends 18 Mar 2019
Shares Drop 40% as Allergy Therapeutics Announces Failed Phase III Trial
…announcement, the shares of Allergy Therapeutics on the London Stock Exchange dropped over 40% within two hours. The phase III trial enrolled 582 people across Europe to test a short-course…
News and Trends 2 Oct 2019
RNA Therapies, Immunotherapies and Cancer Tests Showcased in Spain
…able to treat solid tumors by targeting a cancer antigen called MAGE-A4. The London-based company MiNA Therapeutics reported final phase I data of its RNA therapy in patients with advanced…
News and Trends 6 Mar 2017
The ‘Underdog of the UK?’ 8 Companies Proving the Welsh Biotech Scene
…biotech clusters in the UK like London and Cambridge and picking the top biotechs in Scotland, it’s time to direct our attention to the western part of Great Britain, Wales….
Opinion 10 Nov 2021
Automation Can Solve Diversity Issues in Clinical Trial Recruitment
…morning, while some younger people prefer to receive texts in the afternoon. We are working on a study with Queen Mary University of London in Parkinson’s disease, where diabetes is…
Best in Biotech 22 Dec 2021
The Biggest European Biotech News of 2021
…time as Exscientia’s debut on the Nasdaq, another UK firm, Oxford Nanopore Technologies, went public on the London Stock Exchange. The DNA sequencing behemoth bagged €407.4M (£330M) from its listing,…
Interview 8 Jun 2017
Cambridge Antibody Technology: The History of the UK’s Best Biotech
…together. Our embryonic team gained a lot from that collaboration, and the product ultimately became Humira. In 1996 the Board decided to float the company on the London Stock Exchange,…
